Pituitary Development

The Pituitary, Third Edition

Volumn , Issue , 2010, Pages 3-19

  Drouin, Jacques ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79951695254     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-380926-1.10001-X     Document Type: Chapter

References (157)

1. H. Cushing (1912) The Pituitary Body and Its Disorders. Philadelphia: JB Lippincott
2. G.W. Harris (1948) Neural control of pituitary gland. Physiol Rev 28 139-179.
3. G.W. Harris (1955) The function of the pituitary stalk. Bull. Johns Hopkins Hosp 97(5), 358-375.
4. R. Guillemin (1978) Peptides in the brain: The new endocrinology of the neuron. Science 202(4366), 390-402.
5. G.F. Couly and N.M. Le Douarin (1985) Mapping of the early neural primordium in quail-chick chimeras. I. Developmental relationships between placodes, facial ectoderm, and prosencephalon. Dev Biol 110 422-439.
6. G.F. Couly and N.M. Le Douarin (1987) Mapping of the early neural primordium in quail-chick chimeras. II. The prosencephalic neural plate and neural folds: Implications for the genesis of cephalic human congenital abnormalities. Dev Biol 120 198-214.
7. S. Daikoku, M. Chikamori, T. Adachi and Y. Maki (1982) Effect of the basal diencephalon on the development of Rathke’s pouch in rats: A study in combined organ cultures. Dev Biol 90(1), 198-202.
8. Y.G. Watanabe (1982) Effects of brain and mesenchyme upon the cytogenesis of rat adenohypophysis in vitro. I. Differentiation of adrenocorticotropes. Cell Tissue Res 227(2), 257-266.
9. S. Kikuyama, H. Inaco, B.G. Jenks and K. Kawamura (1993) Development of the ectopically transplanted primordium of epithelial hypophysis (anterior neural ridge) in Bufo japonicus embryos. J Exp Zool 266(3), 216-220.
10. K. Kawamura and S. Kikuyama (1995) Induction from posterior hypothalamus is essential for the development of the pituitary proopiomelacortin (POMC) cells of the toad (Bufo japonicus). Cell Tissue Res 279(2), 233-239.
11. S. Kimura, Y. Hara, T. Pineau, P. Fernandez-Salguero, C.H. Fox, J.M. Ward, et al. (1996) The T/ebp null mouse: Thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. Genes Dev 10 60-69.
12. Y. Zhao, C.M. Mailloux, E. Hermesz, M. Palkovits and H. Westphal (2010) A role of the LIM-homeobox gene Lhx2 in the regulation of pituitary development. Dev Biol 337(2), 313-323.
13. N. Takuma, H.Z. Sheng, Y. Furuta, J.M. Ward, K. Sharma, B.L. Hogan, et al. (1998) Formation of Rathke’s pouch requires dual induction from the diencephalon. Development 125(23), 4835-4840.
14. K. Rizzoti, S. Brunelli, D. Carmignac, P.Q. Thomas, I.C. Robinson and R. Lovell-Badge (2004) SOX3 is required during the formation of the hypothalamo–pituitary axis. Nat Genet 36(3), 247-255.
15. E. Hermesz, L. Williams-Simons and K.A. Mahon (2003) A novel inducible element, activated by contact with Rathke’s pouch, is present in the regulatory region of the Rpx/Hesx1 homeobox gene. Dev Biol 260(1), 68-78.
16. M.A. Charles, H. Suh, J. Drouin, S.A. Camper and P.J. Gage (2005) PITX genes are required for cell survival and Lhx3 activation. Mol Endocrinol 19(7), 1893-1903.
17. T. Lamonerie, J.J. Tremblay, C. Lanctôt, M. Therrien, Y. Gauthier and J. Drouin (1996) PTX1, a bicoid-related homeobox transcription factor involved in transcription of pro-opiomelanocortin (POMC) gene. Genes Dev 10(10), 1284-1295.
18. P.J. Gage, H. Suh and S.A. Camper (1999) The bicoid-related Pitx gene family in development. Mamm Genome 10(2), 197-200.
19. A.K. Ryan, B. Blumberg, C. Rodriguez-Esteban, S. Yonei-Tamura, I. Tamura, T. Tsukui, et al. (1998) Pitx2 determines left-right asymmetry of internal organs in vertebrates. Nature 394(6693), 545-551.
20. P.J. Gage, H.Y. Suh and S.A. Camper (1999) Dosage requirement of Pitx2 for development of multiple organs. Development 126(20), 4643-4651.
21. H. Suh, P.J. Gage, J. Drouin and S.A. Camper (2002) Pitx2 is required at multiple stages of pituitary organogenesis: Pituitary primordium formation and cell specification. Development 129 329-337.
22. D.P. Szeto, C. Rodriguez-Esteban, A.K. Ryan, S.M. O’Connell, F. Liu, C. Kioussi, et al. (1999) Role of the Bicoid-related homeodomain factor Pitx1 in specifying hindlimb morphogenesis and pituitary development. Genes Dev 13(4), 484-494.
23. C. Lanctôt, Y. Gauthier and J. Drouin (1999) Pituitary homeobox 1 (Ptx1) is differentially expressed during pituitary development. Endocrinology 140(3), 1416-1422.
24. H.Z. Sheng, K. Moriyama, T. Yamashita, H. Li, S.S. Potter, K.A. Mahon, et al. (1997) Multistep control of pituitary organogenesis. Science 278(5344), 1809-1812.
25. H.Z. Sheng, A.B. Zhadanov, B. Mosinger, T. Fujii, S. Bertuzzi, A. Grinberg, et al. (1996) Specification of pituitary cell lineages by the LIM homeobox gene Lhx3. Science 272(5264), 1004-1007.
26. I. Netchine, M.L. Sobrier, H. Krude, D. Schnabel, M. Maghnie, E. Marcos, et al. (2000) Mutations in LHX3 result in a new syndrome revealed by combined pituitary hormone deficiency. Nat Genet 25(2), 182-186.
27. K. Machinis, J. Pantel, I. Netchine, J. Leger, O.J. Camand, M.L. Sobrier, et al. (2001) Syndromic short stature in patients with a germline mutation in the LIM homeobox LHX4. Am J Hum Genet 69(5), 961-968.
28. M.L. Sobrier, T. Attie-Bitach, I. Netchine, F. Encha-Razavi, M. Vekemans and S. Amselem (2004) Pathophysiology of syndromic combined pituitary hormone deficiency due to a LHX3 defect in light of LHX3 and LHX4 expression during early human development. Gene Expr Patterns 5(2), 279-284.
29. A.P. Bhangoo, C.S. Hunter, J.J. Savage, H. Anhalt, S. Pavlakis, E.C. Walvoord, et al. (2006) A novel LHX3 mutation presenting as combined pituitary hormonal deficiency. J Clin Endocrinol Metab 91 747-753.
30. P.Q. Thomas, B.V. Johnson, J. Rathjen and P.D. Rathjen (1995) Sequence, genomic organization, and expression of the novel homeobox gene hesx1. J Biol Chem 270(8), 3869-3875.
31. E. Hermesz, S. Mackem and K.A. Mahon (1996) Rpx: A novel anterior-restricted homeobox gene progressively activated in the prechordal plate, anterior neural plate and Rathke’s pouch of the mouse embryo. Development 122(1), 41-52.
32. K. Kawamura and S. Kikuyama (1992) Evidence that hypophysis and hypothalamus constitute a single entity from the primary stage of histogenesis. Development 115 1-9.
33. L.E. Olson, J. Tollkuhn, C. Scafoglio, A. Krones, J. Zhang, K.A. Ohgi, et al. (2006) Homeodomain-mediated beta-catenin-dependent switching events dictate cell-lineage determination. Cell 125(3), 593-605.
34. J.S. Dasen, J.P. Barbera, T.S. Herman, S.O. Connell, L. Olson, B. Ju, et al. (2001) Temporal regulation of a paired-like homeodomain repressor/TLE corepressor complex and a related activator is required for pituitary organogenesis. Genes Dev 15(23), 3193-3207.
35. M.T. Dattani, J.P. Martinez-Barbera, P.Q. Thomas, J.M. Brickman, R. Gupta, I.L. Martensson, et al. (1998) Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Nat Genet 19(2), 125-133.
36. M.L. Brinkmeier, M.A. Potok, K.B. Cha, T. Gridley, S. Stifani, J. Meeldijk, et al. (2003) TCF and Groucho-related genes influence pituitary growth and development. Mol Endocrinol 17(11), 2152-2161.
37. J.M. Brickman, M. Clements, R. Tyrell, D. McNay, K. Woods, J. Warner, et al. (2001) Molecular effects of novel mutations in Hesx1/HESX1 associated with human pituitary disorders. Development 128(24), 5189-5199.
38. M.T. Dattani and I.C. Robinson (2000) The molecular basis for developmental disorders of the pituitary gland in man. Clin Genet 57(5), 337-346.
39. M.T. Dattani (2004) Novel insights into the aetiology and pathogenesis of hypopituitarism. Horm Res 62(Suppl 3), 1-13.
40. M.W. Sornson, W. Wu, J.S. Dasen, S.E. Flynn, D.J. Norman, S.M. O’Connell, et al. (1996) Pituitary lineage determination by the Prophet-of-Pit-1 homeodomain factor defective in Ames dwarfism. Nature 384(6607), 327-333.
41. L.T. Raetzman, R. Ward and S.A. Camper (2002) Lhx4 and Prop1 are required for cell survival and expansion of the pituitary primordia. Development 129(18), 4229-4239.
42. R.D. Ward, L.T. Raetzman, H. Suh, B.M. Stone, I.O. Nasonkin and S.A. Camper (2005) Role of PROP1 in pituitary gland growth. Mol Endocrinol 19(3), 698-710.
43. R.D. Ward, B.M. Stone, L.T. Raetzman and S.A. Camper (2006) Cell proliferation and vascularization in mouse models of pituitary hormone deficiency. Mol Endocrinol 20(6), 1378-1390.
44. P.J. Gage, M.L. Brinkmeier, L.M. Scarlett, L.T. Knapp, S.A. Camper and K.A. Mahon (1996) The ames dwarf gene, df, is required early in pituitary ontogeny for the extinction of rpx transcription and initiation of lineage-specific cell proliferation. Mol Endocrinol 10(12), 1570-1581.
45. I.O. Nasonkin, R.D. Ward, L.T. Raetzman, A.F. Seasholtz, T.L. Saunders, P.J. Gillespie, et al. (2004) Pituitary hypoplasia and respiratory distress syndrome in Prop1 knockout mice. Hum Mol Genet 13(22), 2727-2735.
46. W. Wu, J.D. Cogan, R.W. Pfaffle, J.S. Dasen, H. Frisch, S.M. O’Connell, et al. (1998) Mutations in PROP1 cause familial combined pituitary hormone deficiency. Nat Genet 18(2), 147-149.
47. S. Vallette-Kasic, A. Barlier, C. Teinturier, A. Diaz, M. Manavela, F. Berthezene, et al. (2001) PROP1 gene screening in patients with multiple pituitary hormone deficiency reveals two sites of hypermutability and a high incidence of corticotroph deficiency. J Clin Endocrinol Metab 86(9), 4529-4535.
48. A. Bottner, E. Keller, J. Kratzsch, H. Stobbe, J.F. Weigel, A. Keller, et al. (2004) PROP1 mutations cause progressive deterioration of anterior pituitary function including adrenal insufficiency: A longitudinal analysis. J Clin Endocrinol Metab 89(10), 5256-5265.
49. M. Treier, A.S. Gleiberman, S.M. O’Connell, D.P. Szeto, J.A. McMahon, A.P. McMahon, et al. (1998) Multistep signaling requirements for pituitary organogenesis in vivo. Genes Dev 12(11), 1691-1704.
50. J. Ericson, S. Norlin, T.M. Jessell and T. Edlund (1998) Integrated FGF and BMP signaling controls the progression of progenitor cell differentiation and the emergence of pattern in the embryonic anterior pituitary. Development 125(6), 1005-1015.
51. S.W. Davis and S.A. Camper (2007) Noggin regulates Bmp4 activity during pituitary induction. Dev Biol 305(1), 145-160.
52. M. Nudi, J.F. Ouimette and J. Drouin (2005) Bone morphogenic protein (Smad)-mediated repression of proopiomelanocortin transcription by interference with Pitx/Tpit activity. Mol Endocrinol 19(5), 1329-1342.
53. M. Treier, S. O’Connell, A. Gleiberman, J. Price, D.P. Szeto, R. Burgess, et al. (2001) Hedgehog signaling is required for pituitary gland development. Development 128(3), 377-386.
54. C. Chiang, Y. Litingtung, E. Lee, K.E. Young, J.L. Corden, H. Westphal, et al. (1996) Cyclopia and defective axial patterning in mice lacking Sonic hedgehog gene function. Nature 383(6599), 407-413.
55. H.L. Park, C. Bai, K.A. Platt, M.P. Matise, A. Beeghly, C.C. Hui, et al. (2000) Mouse Gli1 mutants are viable but have defects in SHH signaling in combination with a Gli2 mutation. Development 127(8), 1593-1605.
56. H. Ohuchi, Y. Hori, M. Yamasaki, H. Harada, K. Sekine, S. Kato, et al. (2000) FGF10 acts as a major ligand for FGF receptor 2 IIIb in mouse multi-organ development. Biochem Biophys Res Commun 277(3), 643-649.
57. L. De Moerlooze, B. Spencer-Dene, J. Revest, M. Hajihosseini, I. Rosewell and C. Dickson (2000) An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis. Development 127(3), 483-492.
58. M.L. Brinkmeier, M.A. Potok, S.W. Davis and S.A. Camper (2007) TCF4 deficiency expands ventral diencephalon signaling and increases induction of pituitary progenitors. Dev Biol 311(2), 396-407.
59. J. Chen, N. Hersmus, D.V. Van, P. Caesens, C. Denef and H. Vankelecom (2005) The adult pituitary contains a cell population displaying stem/progenitor cell and early embryonic characteristics. Endocrinology 146(9), 3985-3998.
60. T. Fauquier, K. Rizzoti, M. Dattani, R. Lovell-Badge and I.C. Robinson (2008) SOX2-expressing progenitor cells generate all of the major cell types in the adult mouse pituitary gland. Proc Natl Acad Sci USA 105(8), 2907-2912.
61. M. Garcia-Lavandeira, V. Quereda, I. Flores, C. Saez, E. Diaz-Rodriguez, M.A. Japon, et al. (2009) A GRFa2/Prop1/stem (GPS) cell niche in the pituitary. PLoS ONE 4(3), e4815.
62. A.S. Gleiberman, T. Michurina, J.M. Encinas, J.L. Roig, P. Krasnov, F. Balordi, et al. (2008) Genetic approaches identify adult pituitary stem cells. Proc Nat Acad Sci USA 105(17), 6332-6337.
63. L.T. Raetzman, S.A. Ross, S. Cook, S.L. Dunwoodie, S.A. Camper and P.Q. Thomas (2004) Developmental regulation of Notch signaling genes in the embryonic pituitary: Prop1 deficiency affects Notch2 expression. Dev Biol 265(2), 329-340.
64. L.T. Raetzman, B.S. Wheeler, S.A. Ross, P.Q. Thomas and S.A. Camper (2006) Persistent expression of Notch2 delays gonadotrope differentiation. Mol Endocrinol 20(11), 2898-2908.
65. X. Zhu, J. Zhang, J. Tollkuhn, R. Ohsawa, E.H. Bresnick, F. Guillemot, et al. (2006) Sustained Notch signaling in progenitors is required for sequential emergence of distinct cell lineages during organogenesis. Genes Dev 20(19), 2739-2753.
66. L.T. Raetzman, J.X. Cai and S.A. Camper (2007) Hes1 is required for pituitary growth and melanotrope specification. Dev Biol 304(2), 455-466.
67. A. Kita, I. Imayoshi, M. Hojo, M. Kitagawa, H. Kokubu, R. Ohsawa, et al. (2007) Hes1 and Hes5 control the progenitor pool, intermediate lobe specification, and posterior lobe formation in the pituitary development. Mol Endocrinol 21(6), 1458-1466.
68. P. Monahan, S. Rybak and L.T. Raetzman (2009) The notch target gene HES1 regulates cell cycle inhibitor expression in the developing pituitary. Endocrinology 150(9), 4386-4394.
69. S. Bilodeau, A. Roussel-Gervais and J. Drouin (2009) Distinct developmental roles of cell cycle inhibitors p57Kip2 and p27Kip1 distinguish pituitary progenitor cell cycle exit from cell cycle re-entry of differentiated cells. Mol Cell Biol 29(7), 1895-1908.
70. L.A. Nolan and A. Levy (2006) A population of non-luteinising hormone/non-adrenocorticotrophic hormone-positive cells in the male rat anterior pituitary responds mitotically to both gonadectomy and adrenalectomy. J Neuroendocrinol 18(9), 655-661.
71. A.M. Pulichino, S. Vallette-Kasic, J.P.Y. Tsai, C. Couture, Y. Gauthier and J. Drouin (2003) Tpit determines alternate fates during pituitary cell differentiation. Genes Dev 17(6), 738-747.
72. M. Gulyas, L. Pusztai, G. Rappay and G.B. Makara (1991) Pituitary corticotrophs proliferate temporarily after adrenalectomy. Histochemistry 96(2), 185-189.
73. D. Gregoire and M. Kmita (2008) Recombination between inverted loxP sites is cytotoxic for proliferating cells and provides a simple tool for conditional cell ablation. Proc Nat Acad Sci USA 105(38), 14492-14496.
74. M.A. Japon, M. Rubinstein and M.J. Low (1994) In situ hybridization analysis of anterior pituitary hormone gene expression during fetal mouse development. J Histochem Cytochem 42 1117-1125.
75. S.A. Camper, T.L. Saunders, R.W. Katz and R.H. Reeves (1990) The Pit-1 transcription factor gene is a candidate for the murine snell dwarf mutation. Genomics 8(3), 586-590.
76. S. Li, E.B.I. Crenshaw, E.J. Rawson, D.M. Simmons, L.W. Swanson and M.G. Rosenfeld (1990) Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature 347 528-533.
77. L.E. Cohen and S. Radovick (2002) Molecular basis of combined pituitary hormone deficiencies. Endocr Rev 23(4), 431-442.
78. M.L. Fero, M. Rivkin, M. Tasch, P. Porter, C.E. Carow, E. Firpo, et al. (1996) A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 85(5), 733-744.
79. H. Kiyokawa, R.D. Kineman, K.O. Manova-Todorova, V.C. Soares, E.S. Hoffman, M. Ono, et al. (1996) Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 85(5), 721-732.
80. K. Nakayama, N. Ishida, M. Shirane, A. Inomata, T. Inoue, N. Shishido, et al. (1996) Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85(5), 707-720.
81. S. Jirawatnotai, D.S. Moons, C.O. Stocco, R. Franks, D.B. Hales, G. Gibori, et al. (2003) The cyclin-dependent kinase inhibitors p27Kip1 and p21Cip1 cooperate to restrict proliferative life span in differentiating ovarian cells. J Biol Chem 278(19), 17021-17027.
82. V. Chesnokova, S. Zonis, K. Kovacs, A. Ben Shlomo, K. Wawrowsky, S. Bannykh, et al. (2008) p21(Cip1) restrains pituitary tumor growth. Proc Nat Acad Sci USA 105(45), 17498-17503.
83. V. Chesnokova, S. Zonis, T. Rubinek, R. Yu, A. Ben Shlomo, K. Kovacs, et al. (2007) Senescence mediates pituitary hypoplasia and restrains pituitary tumor growth. Cancer Res 67(21), 10564-10572.
84. V. Chesnokova and S. Melmed (2009) Pituitary tumour-transforming gene (PTTG) and pituitary senescence. Horm Res 71(Suppl 2), 82-87.
85. X. Bonnefont, A. Lacampagne, A. Sanchez-Hormigo, E. Fino, A. Creff, M.N. Mathieu, et al. (2005) Revealing the large-scale network organization of growth hormone-secreting cells. Proc Nat Acad Sci USA 102(46), 16880-16885.
86. C. Lafont, M.G. Desarmenien, M. Cassou, F. Molino, J. Lecoq, D. Hodson, et al. (2010) Cellular in vivo imaging reveals coordinated regulation of pituitary microcirculation and GH cell network function. Proc Nat Acad Sci USA 107(9), 4465-4470.
87. N. Chauvet, T. El Yandouzi, M.N. Mathieu, A. Schlernitzauer, E. Galibert, C. Lafont, et al. (2009) Characterization of adherens junction protein expression and localization in pituitary cell networks. J Endocrinol 202(3), 375-387.
88. B. Lamolet, A.M. Pulichino, T. Lamonerie, Y. Gauthier, T. Brue, A. Enjalbert, et al. (2001) A pituitary cell-restricted T-box factor, Tpit, activates POMC transcription in cooperation with Pitx homeo-proteins. Cell 104(6), 849-859.
89. A.M. Pulichino, S. Vallette-Kasic, C. Couture, Y. Gauthier, T. Brue, M. David, et al. (2003) Human and mouse Tpit gene mutations cause early onset pituitary ACTH deficiency. Genes Dev 17(6), 711-716.
90. S. Vallette-Kasic, T. Brue, A.M. Pulichino, M. Gueydan, A. Barlier, M. David, et al. (2005) Congenital isolated adrenocorticotropin deficiency: An underestimated cause of neonatal death, explained by TPIT gene mutations. J Clin Endocrinol Metab 90(3), 1323-1331.
91. S. Vallette-Kasic, C. Couture, A. Balsalobre, Y. Gauthier, L.A. Metherell, M. Dattani, et al. (2007) The TPIT gene mutation M86R associated with isolated ACTH deficiency interferes in protein:protein interactions. J Clin Endocrinol Metab. 92(10), 3991-3999.
92. S. Vallette-Kasic, D. Figarella-Branger, M. Grino, A.M. Pulichino, H. Dufour, F. Grisoli, et al. (2003) Differential regulation of proopiomelanocortin and pituitary-restricted transcription factor (TPIT), a new marker of normal and adenomatous human corticotrophs. J Clin Endocrinol Metab 88(7), 3050-3056.
93. M. Therrien and J. Drouin (1993) Cell-specific helix-loop-helix factor required for pituitary expression of the pro-opiomelanocortin gene. Mol Cell Biol 13 2342-2353.
94. G. Poulin, B. Turgeon and J. Drouin (1997) NeuroD1/BETA2 contributes to cell-specific transcription of the POMC gene. Mol Cell Biol 17(11), 6673-6682.
95. G. Poulin, M. Lebel, M. Chamberland, F.W. Paradis and J. Drouin (2000) Specific protein:protein interaction between basic Helix-Loop-Helix transcription factors and homeoproteins of the Pitx family. Mol Cell Biol 20 4826-4837.
96. P.L. Lavoie, L. Budry, A. Balsalobre and J. Drouin (2008) Developmental Dependence on NurRE and EboxNeuro for Expression of Pituitary POMC. Mol Endocrinol 22(7), 1647-1657.
97. G.W. Smith, J.M. Aubry, F. Dellu, A. Contarino, L.M. Bilezikjian, L.H. Gold, et al. (1998) Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 20(6), 1093-1102.
98. T.L. Bale, R. Picetti, A. Contarino, G.F. Koob, W.W. Vale and K.F. Lee (2002) Mice deficient for both corticotropin-releasing factor receptor 1 (CRFR1) and CRFR2 have an impaired stress response and display sexually dichotomous anxiety-like behavior. J Neurosci 22(1), 193-199.
99. D.I. Lugo and J.E. Pintar (1996) Ontogeny of basal and regulated secretion from POMC cells of the developing anterior lobe of the rat pituitary gland. Dev Biol 173(1), 95-109.
100. D.I. Lugo and J.E. Pintar (1996) Ontogeny of basal and regulated proopiomelanocortin-derived peptide secretion from fetal and neonatal pituitary intermediate lobe cells: Melanotrophs exhibit transient glucocorticoid responses during development. Dev Biol 173(1), 110-118.
101. I. Heuser (1998) Anna-Monika-Prize paper. The hypothalamic-pituitary-adrenal system in depression. Pharmacopsychiatry 31(1), 10-13.
102. F. Holsboer and N. Barden (1996) Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr Rev 17(2), 187-205.
103. F. Holsboer, R. Liebl and E. Hofschuster (1982) Repeated dexamethasone suppression test during depressive illness. Normalisation of test result compared with clinical improvement. J Affect Disord 4(2), 93-101.
104. C.B. Nemeroff, E. Widerlov, G. Bissette, H. Walleus, I. Karlsson, K. Eklund, et al. (1984) Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 226(4680), 1342-1344.
105. T.W. Pace, F. Hu and A.H. Miller (2007) Cytokine-effects on glucocorticoid receptor function: Relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav Immun 21(1), 9-19.
106. S. Watson, P. Gallagher, I.N. Ferrier and A.H. Young (2006) Post-dexamethasone arginine vasopressin levels in patients with severe mood disorders. J Psychiatr Res 40(4), 353-359.
107. C. Schule, T.C. Baghai, D. Eser and R. Rupprecht (2009) Hypothalamic-pituitary-adrenocortical system dysregulation and new treatment strategies in depression. Expert Rev Neurother 9(7), 1005-1019.
108. S.W.J. Lamberts (2002) Glucocorticoid receptors and Cushing’s disease. Mol Cell Endocrinol 197(1–2), 69-72.
109. S. Bilodeau, S. Vallette-Kasic, Y. Gauthier, D. Figarella-Branger, T. Brue, F. Berthelet, et al. (2006) Role of Brg1 and HDAC2 in GR trans-repression of pituitary POMC gene and misexpression in Cushing disease. Genes Dev 20(20), 2871-2886.
110. L. Proulx-Ferland, H. Meunier, J. Côté, D. Dumont, B. Gagné and F. Labrie (1983) Multiple factors involved in the control of ACTH and a-MSH secretion. J Steroid Biochem 19 439-445.
111. H.A. Ingraham, D.S. Lala, Y. Ikeda, X. Luo, W.H. Shen, M.W. Nachtigal, et al. (1994) The nuclear receptor steroidogenic factor 1 acts at multiple levels of the reproductive axis. Genes Dev 8 2302-2312.
112. Y. Ikeda, D.S. Lala, X. Luo, E. Kim, M.P. Moisan and K.L. Parker (1993) Characterization of the mouse FTZ-F1 gene, which encodes a key regulator of steroid hydroxylase gene expression. Mol Endocrinol 7(7), 852-860.
113. Y. Ikeda, W.H. Shen, H.A. Ingraham and K.L. Parker (1994) Developmental expression of mouse steroidogenic factor-1, an essential regulator of the steroid hydroxylases. Mol Endocrinol 8(5), 654-662.
114. X. Luo, Y. Ikeda and K.L. Parker (1994) A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 77(4), 481-490.
115. K. Shinoda, H. Lei, H. Yoshii, M. Nomura, M. Nagano, H. Shiba, et al. (1995) Developmental defects of the ventromedial hypothalamic nucleus and pituitary gonadotroph in the Ftz-F1 disrupted mice. Dev Dyn 204(1), 22-29.
116. L. Zhao, M. Bakke, Y. Krimkevich, L.J. Cushman, A.F. Parlow, S.A. Camper, et al. (2001) Steroidogenic factor 1 (SF1) is essential for pituitary gonadotrope function. Development 128(2), 147-154.
117. Y. Ikeda, X. Luo, R. Abbud, J.H. Nilson and K.L. Parker (1995) The nuclear receptor steroidogenic factor 1 is essential for the formation of the ventromedial hypothalamic nucleus. Mol Endocrinol 9(4), 478-486.
118. P. Topilko, S. Schneider-Maunoury, G. Levi, A. Trembleau, D. Gourdji, M.A. Driancourt, et al. (1998) Multiple pituitary and ovarian defects in Krox-24 (NGFI-A, Egr-1)-targeted mice. Mol Endocrinol 12(1), 107-122.
119. J.J. Tremblay and J. Drouin (1999) Egr-1 is a downstream effector of GnRH and synergizes by direct interaction with Ptx1 and SF-1 to enhance luteinizing hormone b gene transcription. Mol Cell Biol 19(4), 2567-2576.
120. C. Dorn, Q. Ou, J. Svaren, P.A. Crawford and Y. Sadovsky (1999) Activation of luteinizing hormone beta gene by gonadotropin-releasing hormone requires the synergy of early growth response-1 and steroidogenic factor-1. J Biol Chem 274(20), 13870-13876.
121. M.W. Wolfe and G.B. Call (1999) Early growth response protein 1 binds to the luteinizing hormone-beta promoter and mediates gonadotropin-releasing hormone-stimulated gene expression. Mol Endocrinol 13(5), 752-763.
122. M.A. Charles, T.L. Saunders, W.M. Wood, K. Owens, A.F. Parlow, S.A. Camper, et al. (2006) Pituitary-specific Gata2 knockout: Effects on gonadotrope and thyrotrope function. Mol Endocrinol 20(6), 1366-1377.
123. J.S. Dasen, S.M. O’Connell, S.E. Flynn, M. Treier, A.S. Gleiberman, et al. (1999) Reciprocal interactions of Pit1 and GATA2 mediate signaling gradient-induced determination of pituitary cell types. Cell 97(5), 587-598.
124. D.P. Szeto, A.K. Ryan, S.M. O’Connell and M.G. Rosenfeld (1996) P-OTX: A PIT-1-interacting homeodomain factor expressed during anterior pituitary gland development. Proc Nat Acad Sci USA 93(15), 7706-7710.
125. C.C. Quirk, K.L. Lozada, R.A. Keri and J.H. Nilson (2001) A single Pitx1 binding site is essential for activity of the LHbeta promoter in transgenic mice. Mol Endocrinol 15(5), 734-746.
126. M.M. Zakaria, K.H. Jeong, C. Lacza and U.B. Kaiser (2002) Pituitary homeobox 1 activates the rat FSHbeta (rFSHbeta) gene through both direct and indirect interactions with the rFSHbeta gene promoter. Mol Endocrinol 16(8), 1840-1852.
127. D. Acampora, S. Mazan, F. Tuorto, V. Avantaggiato, J.J. Tremblay, D. Lazzaro, et al. (1998) Transient dwarfism and hypogonadism in mice lacking Otx1 reveal prepubescent stage-specific control of pituitary levels of GH. FSH and LH. Development 125(7), 1229-1239.
128. T. Tajima, A. Ohtake, M. Hoshino, S. Amemiya, N. Sasaki, K. Ishizu, et al. (2009) OTX2 loss of function mutation causes anophthalmia and combined pituitary hormone deficiency with a small anterior and ectopic posterior pituitary. J Clin Endocrinol Metab 94(1), 314-319.
129. B. Andersen and M.G. Rosenfeld (2001) POU domain factors in the neuroendocrine system: Lessons from developmental biology provide insights into human disease. Endocr Rev 22(1), 2-35.
130. M. Bodner, J.L. Castrillo, L.E. Theill, T. Deerinck, M. Ellisman and M. Karin (1988) The pituitary-specific transcription factor GHF-1 is a homeobox-containing protein. Cell 55(3), 505-518.
131. H.A. Ingraham, R. Chen, H.J. Mangalam, H.P. Elsholtz, S.E. Flynn, C.R. Lin, et al. (1988) A tissue-specific transcription factor containing a homeodomain specifies a pituitary phenotype. Cell 55(3), 519-529.
132. G. Nica, W. Herzog, C. Sonntag and M. Hammerschmidt (2004) Zebrafish pit1 mutants lack three pituitary cell types and develop severe dwarfism. Mol Endocrinol 18(5), 1196-1209.
133. Y. Qi, J.A. Ranish, X. Zhu, A. Krones, J. Zhang, R. Aebersold, et al. (2008) Atbf1 is required for the Pit1 gene early activation. Proc Nat Acad Sci USA 105(7), 2481-2486.
134. S.J. Rhodes, R. Chen, G.E. DiMattia, K.M. Scully, K.A. Kalla, S.C. Lin, et al. (1993) A tissue-specific enhancer confers Pit-1-dependent morphogen inducibility and autoregulation on the pit-1 gene. Genes Dev 7 913-932.
135. P.E. Mullis (2005) Genetic control of growth. Eur J Endocrinol 152(1), 11-31.
136. R.N. Day, S. Koike, M. Sakai, M. Muramatsu and R.A. Maurer (1990) Both pit-1 and the estrogen receptor are required for estrogen responsiveness of the rat prolactin gene. Mol Endocrinol 4(12), 1964-1971.
137. E.B. Crenshaw III, K. Kalla, D.M. Simmons, L.W. Swanson and M.G. Rosenfeld (1989) Cell-specific expression of the prolactin gene in transgenic mice is controlled by synergistic interactions between promoter and enhancer elements. Genes Dev 3 959-972.
138. B.E. Nowakowski and R.A. Maurer (1994) Multiple Pit-1-binding sites facilitate estrogen responsiveness of the prolactin gene. Mol Endocrinol 8(12), 1742-1749.
139. K.M. Scully, A.S. Gleiberman, J. Lindzey, D.B. Lubahn, K.S. Korach and M.G. Rosenfeld (1997) Role of estrogen receptor-alpha in the anterior pituitary gland. Mol Endocrinol 11(6), 674-681.
140. A. Gutierrez-Hartmann, D.L. Duval and A.P. Bradford (2007) ETS transcription factors in endocrine systems. Trends Endocrinol Metab 18(4), 150-158.
141. A.P. Bradford, C. Wasylyk, B. Wasylyk and A. Gutierrez-Hartmann (1997) Interaction of Ets-1 and the POU-homeodomain protein GHF-1/Pit-1 reconstitutes pituitary-specific gene expression. Mol Cell Biol 17(3), 1065-1074.
142. A.P. Bradford, K.E. Conrad, C. Wasylyk, B. Wasylyk and A. Gutierrez-Hartmann (1995) Functional interaction of c-Ets-1 and GHF-1/Pit-1 mediates Ras activation of pituitary-specific gene expression: Mapping of the essential c-Ets-1 domain. Mol Cell Biol 15(5), 2849-2857.
143. B. Wasylyk, J. Hagman and A. Gutierrez-Hartmann (1998) Ets transcription factors: Nuclear effectors of the Ras-MAP-kinase signaling pathway. Trends Biochem Sci 23(6), 213-216.
144. A.P. Bradford, K.E. Conrad, P.H. Tran, M.C. Ostrowski and A. Gutierrez-Hartmann (1996) GHF-1/Pit-1 functions as a cell-specific integrator of Ras signaling by targeting the Ras pathway to a composite Ets-1/GHF-1 response element. J Biol Chem 271(40), 24639-24648.
145. R.E. Schweppe, A.A. Melton, K.S. Brodsky, L.D. Aveline, K.A. Resing, N.G. Ahn, et al. (2003) Purification and mass spectrometric identification of GA-binding protein (GABP) as the functional pituitary Ets factor binding to the basal transcription element of the prolactin promoter. J Biol Chem 278(19), 16863-16872.
146. J.J. Tremblay, C. Lanctôt and J. Drouin (1998) The pan-pituitary activator of transcription, Ptx-1 (pituitary homeobox1), acts in synergy with SF-1 and Pit1 and is an upstream regulator of the Lim-homeodomain gene Lim3/Lhx3. Mol Endocrinol 12(3), 428-441.
147. J.J. Tremblay, C.G. Goodyer and J. Drouin (2000) Transcriptional properties of Ptx1 and Ptx2 isoforms. Neuroendocrinol 71 277-286.
148. M.H. Quentien, I. Manfroid, D. Moncet, G. Gunz, M. Muller, M. Grino, et al. (2002) Pitx factors are involved in basal and hormone-regulated activity of the human prolactin promoter. J Biol Chem 277(46), 44408-44416.
149. K.K. Jacob and F.M. Stanley (1999) CCAAT/enhancer-binding protein alpha is a physiological regulator of prolactin gene expression. Endocrinology 140(10), 4542-4550.
150. J.C. Liu, R.E. Baker, C. Sun, V.C. Sundmark and H.P. Elsholtz (2002) Activation of Go-coupled dopamine D2 receptors inhibits ERK1/ERK2 in pituitary cells. A key step in the transcriptional suppression of the prolactin gene. J Biol Chem 277(39), 35819-35825.
151. A. Saiardi, Y. Bozzi, J.H. Baik and E. Borrelli (1997) Antiproliferative role of dopamine: Loss of D2 receptors causes hormonal dysfunction and pituitary hyperplasia. Neuron 19(1), 115-126.
152. S.L. Asa, M.A. Kelly, D.K. Grandy and M.J. Low (1999) Pituitary lactotroph adenomas develop after prolonged lactotroph hyperplasia in dopamine D2 receptor-deficient mice. Endocrinology 140(11), 5348-5355.
153. D.F. Gordon, S.R. Lewis, B.R. Haugen, R.A. James, M.T. Mcdermott, W.M. Wood, et al. (1997) Pit-1 and GATA-2 interact and functionally cooperate to activate the thyrotropin beta-subunit promoter. J Biol Chem 272(39), 24339-24347.
154. K. Hashimoto, M. Yamada, T. Monden, T. Satoh, F.E. Wondisford and M. Mori (2005) Thyrotropin-releasing hormone (TRH) specific interaction between amino terminus of P-Lim and CREB binding protein (CBP). Mol Cell Endocrinol 229(1–2), 11-20.
155. K. Hashimoto, K. Zanger, A.N. Hollenberg, L.E. Cohen, S. Radovick and F.E. Wondisford (2000) cAMP response element-binding protein-binding protein mediates thyrotropin-releasing hormone signaling on thyrotropin subunit genes. J Biol Chem 275(43), 33365-33372.
156. S. Sasaki, L.A. Lesoon-Wood, A. Dey, T. Kuwata, B.D. Weintraub, G. Humphrey, et al. (1999) Ligand-induced recruitment of a histone deacetylase in the negative-feedback regulation of the thyrotropin beta gene. EMBO J 18(19), 5389-5398.
157. E.D. Abel, E.G. Moura, R.S. Ahima, A. Campos-Barros, C.C. Pazos-Moura, M.E. Boers, et al. (2003) Dominant inhibition of thyroid hormone action selectively in the pituitary of thyroid hormone receptor-beta null mice abolishes the regulation of thyrotropin by thyroid hormone. Mol Endocrinol 17(9), 1767-1776.